Biomarin Pharmaceutical Inc (BMRN)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 2,845,320 | 2,374,190 | 2,068,670 | 1,832,750 | 1,823,140 |
| Total assets | US$ in thousands | 6,988,940 | 6,841,600 | 6,375,070 | 6,004,770 | 5,848,020 |
| Total asset turnover | 0.41 | 0.35 | 0.32 | 0.31 | 0.31 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $2,845,320K ÷ $6,988,940K
= 0.41
The total asset turnover ratio for Biomarin Pharmaceutical Inc has shown a consistent increase over the past five years, starting at 0.31 in December 2020 and reaching 0.41 by December 2024. This improvement indicates that the company is generating more revenue relative to its total assets, reflecting increased efficiency in asset utilization. The rise in total asset turnover suggests that Biomarin Pharmaceutical Inc has been able to effectively manage its assets to generate higher sales, which is a positive indicator of operational effectiveness and potentially improving financial performance over the years.
Peer comparison
Dec 31, 2024